Cape Investment Advisory’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$158K Buy
+5,510
New +$175K 0.04% 271
2026
Q1
Sell
-3,154
Closed -$92.9K 989
2025
Q4
$92.9K Buy
3,154
+536
+20% +$14.9K 0.03% 316
2025
Q3
$66.1K Buy
2,618
+38
+1% +$926 0.07% 195
2025
Q2
$61.9K Buy
2,580
+61
+2% +$1.41K 0.02% 340
2025
Q1
$57.7K Buy
2,519
+1,014
+67% +$24.5K 0.02% 320
2024
Q4
$38.1K Buy
1,505
+594
+65% +$15.1K 0.01% 367
2024
Q3
$22.7K Buy
911
+229
+34% +$6.78K 0.01% 437
2024
Q2
$20.2K Sell
682
-60
-8% -$1.66K 0.01% 421
2024
Q1
$22.4K Buy
+742
New +$20.6K 0.01% 427

Other funds holding RTO

Cape Investment Advisory's RTO Position: Q2 2026 in Review

Cape Investment Advisory opened a new position in Rentokil (RTO) in Q2 2026: 5,510 shares worth $158K. The stake represents 0.04% of the portfolio and ranks #271 among its holdings. This is a return to the name: Cape Investment Advisory previously reported a position in RTO as recently as Q4 2025.

Cape Investment Advisory first reported a position in RTO in Q1 2024 and has held it in 9 quarters since. 284 funds tracked by Wall St. Rank hold RTO as of Q2 2026.

  • Cape Investment Advisory held 5,510 shares of Rentokil worth $158K as of Q2 2026.
  • Rentokil was a new Cape Investment Advisory position in Q2 2026.
  • Rentokil made up 0.04% of Cape Investment Advisory's portfolio in Q2 2026, its #271 holding.
  • Cape Investment Advisory first reported a position in Rentokil in Q1 2024 and has held it in 9 quarters since.
  • 284 funds tracked by Wall St. Rank held Rentokil as of Q2 2026.

Based on Cape Investment Advisory's 13F filing for Q2 2026, filed 23 Jul 2026.